HK1255631A1 - 用於預防和治療睡眠障礙的藥物組合物 - Google Patents

用於預防和治療睡眠障礙的藥物組合物

Info

Publication number
HK1255631A1
HK1255631A1 HK18114767.2A HK18114767A HK1255631A1 HK 1255631 A1 HK1255631 A1 HK 1255631A1 HK 18114767 A HK18114767 A HK 18114767A HK 1255631 A1 HK1255631 A1 HK 1255631A1
Authority
HK
Hong Kong
Prior art keywords
preventing
pharmaceutical composition
sleep disorders
treating sleep
treating
Prior art date
Application number
HK18114767.2A
Other languages
English (en)
Inventor
弗拉基米爾‧維克托羅維奇‧涅斯捷魯克
基里爾‧康斯坦丁諾維奇‧瑟羅夫
Original Assignee
瓦倫塔有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瓦倫塔有限責任公司 filed Critical 瓦倫塔有限責任公司
Publication of HK1255631A1 publication Critical patent/HK1255631A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK18114767.2A 2016-02-18 2018-11-19 用於預防和治療睡眠障礙的藥物組合物 HK1255631A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2016105535A RU2620855C1 (ru) 2016-02-18 2016-02-18 Фармацевтическая композиция для профилактики и лечения нарушений сна
PCT/RU2017/000077 WO2017142442A1 (ru) 2016-02-18 2017-02-16 Фармацевтическая композиция для профилактики и лечения нарушений сна

Publications (1)

Publication Number Publication Date
HK1255631A1 true HK1255631A1 (zh) 2019-08-23

Family

ID=59032329

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114767.2A HK1255631A1 (zh) 2016-02-18 2018-11-19 用於預防和治療睡眠障礙的藥物組合物

Country Status (9)

Country Link
KR (1) KR20180101539A (zh)
CN (1) CN108697645A (zh)
BR (1) BR112018016725A2 (zh)
CL (1) CL2018002337A1 (zh)
EA (1) EA201891647A1 (zh)
HK (1) HK1255631A1 (zh)
MX (1) MX2018009921A (zh)
RU (1) RU2620855C1 (zh)
WO (1) WO2017142442A1 (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063297A2 (en) * 2003-12-24 2005-07-14 Sepracor Inc. Melatonin combination therapy for improving sleep quality
WO2012170883A1 (en) * 2011-06-09 2012-12-13 Discovery Pharma Consulting, Llc Antihistamines combined with dietary supplements for improved health
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
DK2964185T3 (da) * 2013-03-05 2022-02-14 Requis Pharmaceuticals Inc Præparater til behandlingen af søvnrelaterede luftvejslidelser

Also Published As

Publication number Publication date
BR112018016725A2 (pt) 2019-04-30
MX2018009921A (es) 2018-11-09
RU2620855C1 (ru) 2017-05-30
WO2017142442A1 (ru) 2017-08-24
CL2018002337A1 (es) 2018-11-30
CN108697645A (zh) 2018-10-23
EA201891647A1 (ru) 2018-12-28
KR20180101539A (ko) 2018-09-12

Similar Documents

Publication Publication Date Title
IL256085B (en) A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment
ZA201907158B (en) Methods and compositions for treating sleep apnea
HRP20210518T1 (hr) Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava
IL269174A (en) Methods for treating binding-mediated diseases or disorders
ZA201901055B (en) Treatment and prevention of sleep disorders
PL3362449T3 (pl) Pochodne sybiriliny do zastosowania do zapobiegania i/lub leczenia zaburzeń związanych z nekroptozą komórkową
HK1252813A1 (zh) 用於治療社交障礙和藥物使用障礙的治療性化合物和組合物
HK1258696A1 (zh) 治療或預防皮膚障礙的新型組合物和方法
HK1257935A1 (zh) 氨基糖苷衍生物及其在治療遺傳性病症中的應用
EP3677265A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF SLEEP DISORDERS
HK1257587A1 (zh) 預防和治療肝纖維化的藥物及其用途
IL250114A0 (en) Methods and compositions for the treatment of hiv-related diseases
EP3262065C0 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DYSTROGLYCANOPATHY DISEASES
IL280389A (en) Bile acid receptor modulators conjugated to G.1 protein and methods of using them
PL3290051T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi
PT3236961T (pt) Composição farmacêutica para prevenir ou tratar cancro
GB201519644D0 (en) Therapy and pharmaceutical composition
HUE065421T2 (hu) Nazális adagolású rifampicint tartalmazó gyógyszerészeti készítmény demencia kezelésére
EP3552632A4 (en) MEDICINAL COMPOSITION FOR TREATING AND PREVENTING CHRONIC DISEASE
HK1255631A1 (zh) 用於預防和治療睡眠障礙的藥物組合物
AU2017902338A0 (en) Sleep Disorder Composition and Treatment Thereof
AU2015902659A0 (en) Therapeutic compounds and compositions for treating social disorders and substance use disorders